Neurogene Inc.

General ticker "NGNE" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $441.7M (TTM average)

Neurogene Inc. follows the US Stock Market performance with the rate: 37.9%.

Estimated limits based on current volatility of 3.9%: low 28.68$, high 31.01$

Factors to consider:

  • Total employees count: 91 as of 2023
  • Price in estimated range
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [14.19$, 33.81$]
  • 2026-12-31 to 2027-12-31 estimated range: [11.37$, 28.07$]

Financial Metrics affecting the NGNE estimates:

  • Negative: with PPE of -4.8 at the end of fiscal year the price was high
  • Negative: negative Operating cash flow
  • Negative: negative Operating income
  • Negative: negative Net income
  • Positive: Inventory ratio change, % of 0 <= 0
  • Positive: Investing cash flow per share per price, % of 3.26 > -0.60
  • Positive: Shareholder equity ratio, % of 91.78 > 64.29
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Interest expense per share per price, % of 0 <= 0.01

Similar symbols

Short-term NGNE quotes

Long-term NGNE plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.93MM $0.00MM
Operating Expenses $55.58MM $83.53MM $103.33MM
Operating Income $-55.58MM $-82.61MM $-103.33MM
Non-Operating Income $19.27MM $7.46MM $12.98MM
Interest Expense $0.01MM $0.01MM $0.01MM
R&D Expense $44.39MM $60.92MM $75.01MM
Income(Loss) $-36.32MM $-75.14MM $-90.35MM
Net Income(Loss)* $-36.32MM $-75.14MM $-90.35MM
Stockholders Equity $186.02MM $310.38MM $264.89MM
Assets $222.57MM $335.73MM $288.60MM
Operating Cash Flow $-51.42MM $-70.60MM $-77.17MM
Capital expenditure $0.32MM $0.81MM $1.18MM
Investing Cash Flow $25.64MM $-125.26MM $14.00MM
Financing Cash Flow $92.48MM $184.07MM $30.43MM
Earnings Per Share** $-2.83 $-4.28 $-4.27

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.